Join Us On LinkedIn

Akorn Inc and two former executives have agreed to settle claims stemming from inaccurate financial statements the generic drugmaker issued in 2014 that it later needed to restate, the U.S. Securities and Exchange Commission on Monday said. via Akorn settles U.S. SEC claims stemming from financial restatement.
As I have noted before, the phenomenon of event-driven litigation has recently emerged as a significant factor in the level of securities class action filings. I distinguish this category of litigation from the kinds of allegations that in the past characterized securities litigation – that is, allegations based on financial misrepresentation or financial omissions. As […]
Securities class actions soared in 2017, jumping from 271 filings in 2016 to a near record 412 filings in 2017 — well above the average of 193 per year for the years 1997 to 2016. Only 2001 was comparable, although both 2001 and 2017 were inflated by special factors. Now add to this growth the […]